A Study of Ramucirumab Combination Therapy in Japanese Participants Who Have Advanced Stomach Cancer
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and
antitumor response of ramucirumab in combination with platinum/fluoropyrimidine regimens in
Japanese participants with advanced gastric/gastrooesophageal junction cancer who have not
received chemotherapy.